OptiNose (OPTN) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL

6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Optinose Reports Second Quarter 2022 Financial Results and Operational Updates

August 11, 2022 7:00 AM EDT

Company reports second quarter XHANCE net revenue of $20.6 million increased 12%

compared to second quarter 2021

Company plans to submit an sNDA for XHANCE as a treatment for chronic sinusitis by the end of 2022

Company expects full year 2022 XHANCE net revenue to be between $85 to $92 million

Company expects full year 2022 and operating expenses to be between $129 to $134 million

Conference call and webcast to be held today at 8:00 a.m. Eastern Time

YARDLEY, Pa., Aug.... More